We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.69%
5 Year Est. Return
+105.13%
10 Year Est. Return
AUM
$4.46B
AUM Growth
-$149M
Cap. Flow
-$295M
Cap. Flow %
-6.6%
Top 10 Hldgs %
26.75%
Holding
132
New
15
Increased
6
Reduced
19
Closed
9

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$56M
2
MYGN icon
Myriad Genetics
MYGN
+$43.1M
3
KEX icon
Kirby Corp
KEX
+$32.7M
4
CVE icon
Cenovus Energy
CVE
+$26.1M
5
TXN icon
Texas Instruments
TXN
+$23.3M

Sector Composition

Rank Sector Weight
1 Technology 25.45%
2 Healthcare 19.62%
3 Financials 11.73%
4 Industrials 10.85%
5 Consumer Discretionary 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMPR icon
101
Cimpress
CMPR
$2.49B
$7.47M 0.17%
+184,732
New +$8.03M
HSTM icon
102
HealthStream
HSTM
$896M
$7.3M 0.16%
+300,600
New +$7.48M
HOS
103
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$7.04M 0.16%
150,000
UTHR icon
104
United Therapeutics
UTHR
$22B
$6.73M 0.15%
76,000
FOXF icon
105
Fox Factory Holding Corp
FOXF
$816M
$6.68M 0.15%
379,700
MDSO
106
DELISTED
Medidata Solutions, Inc.
MDSO
$5.35M 0.12%
+125,000
New +$5.19M
MG icon
107
Mistras Group
MG
$503M
$4.9M 0.11%
200,000
CSGP icon
108
CoStar Group
CSGP
$12.1B
$4.75M 0.11%
+300,000
New +$4.86M
ZGNX
109
DELISTED
Zogenix, Inc.
ZGNX
$4.42M 0.1%
275,000
OREX
110
DELISTED
Orexigen Therapeutics, Inc.
OREX
$4.33M 0.1%
70,000
TVRD
111
Tvardi Therapeutics
TVRD
$18.9M
$4.25M 0.1%
6,944
VOLC
112
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$4.13M 0.09%
234,454
-742,578
-76% -$13.5M
AMBR
113
DELISTED
Amber Road Inc
AMBR
$3.99M 0.09%
+247,700
New +$3.55M
QTWO icon
114
Q2 Holdings
QTWO
$3.98B
$3.58M 0.08%
+251,200
New +$3.41M
ZION icon
115
Zions Bancorporation
ZION
$10.5B
$2.95M 0.07%
100,000
SPSC icon
116
SPS Commerce
SPSC
$2.67B
$2.42M 0.05%
+76,600
New +$2.14M
EGLT
117
DELISTED
Egalet Corporation
EGLT
$2.36M 0.05%
180,100
+30,100
+20% +$377K
PRLB icon
118
Protolabs
PRLB
$2.11B
$2.3M 0.05%
+28,100
New +$1.9M
OXFD
119
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.93M 0.04%
+114,455
New +$2.06M
TYL icon
120
Tyler Technologies
TYL
$12.8B
$1.28M 0.03%
+14,089
New +$1.14M
STAA icon
121
STAAR Surgical
STAA
$1.21B
$1.22M 0.03%
+72,826
New +$1.2M
DRNA
122
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$903K 0.02%
40,000
LCII icon
123
LCI Industries
LCII
$2.56B
$776K 0.02%
+15,519
New +$774K
CSCO icon
124
Cisco
CSCO
$477B
-2,500,000
Closed -$56M
CVE icon
125
Cenovus Energy
CVE
$53.3B
-900,000
Closed -$26.1M

Similar funds

Tiverton Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Tiverton Asset Management held 132 positions worth $4.46B, down 3.2% from $4.61B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tiverton Asset Management withdrew a net $295M in Q2 2014, closing 9 positions and reducing 19 holdings. Its most notable exit was Cisco, an estimated $56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Tiverton Asset Management opened a new position in ZULILY INC CLASS A COMMON STOCK worth $26.2M.

  • Tiverton Asset Management's largest Q2 2014 buy was ZULILY INC CLASS A COMMON STOCK: 639,000 shares worth $26.2M.
  • Tiverton Asset Management added most to Gilead Sciences in Q2 2014, an estimated $31.1M increase.
  • Tiverton Asset Management's biggest Q2 2014 reduction was Myriad Genetics, cutting an estimated $43.1M.
  • Tiverton Asset Management fully exited Cisco in Q2 2014, selling an estimated $56M.
  • Tiverton Asset Management's ten largest holdings make up 27% of its $4.46B portfolio in Q2 2014.
  • Tiverton Asset Management opened 15 new positions and closed 9 in Q2 2014.
  • Tiverton Asset Management's portfolio value fell 3.2% quarter-over-quarter to $4.46B.

Based on Tiverton Asset Management's 13F filing for Q2 2014, filed 6 Aug 2014.